Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Connected selfcare: setting a new standard

Whitepaper – How to establish clear measurable outcome metrics that align technology with therapeutic goals and couple robust data generation strategies with holistic patient experience and treatment efficacy.

Automated assembly for fast-track design verification of YpsoMate platforms

Discover how Ypsomed’s innovative in-house assembly system streamlines workflows, enhances precision and slashes verification times, helping customers bring their products to market with speed and confidence.

Advancing large-volume subcutaneous drug delivery

What are the latest trends in large-volume drug delivery? A recent study explores key developments, while Ypsomed’s innovative injection platforms address the challenges of large volumes and high viscosities with patient-friendly solutions.

CE-certified reusable pens: Immediate certification for market access

Discover how Ypsomed’s CE-certified reusable pens, ServoPen and YpsoPen, streamline market access. Our innovative platform model simplifies compliance, accelerates product availability, and provides comprehensive support to pharmaceutical partners at …

High performance in high-dose drug delivery

Discover how Ypsomed’s advanced delivery devices, including YpsoMate and YpsoDose, empower high-dose drug delivery. From viscosities to volumes, our innovative platforms transform patient care and enable pharmaceutical success. Explore the solutions …

Device-enabled digital health solutions

White paper – Discover which business opportunities digital health solutions enable for pharmaceutical companies, starting from research and development, expanding to commercialisation through pre-launch, expansion, maturity and loss of exclusivity.​

Digital selfcare – Solving patient challenges while delivering business insights to pharma​

Article – Discover how digital health solutions make selfcare simpler and easier for patients while also facilitating research and development, market access and commercial success for pharmaceutical companies.​

First Deliveries of YpsoMate 1 mL as part of the NetZero Program

Ypsomed supplied first batches of YpsoMate 1 mL with a reduced carbon footprint as part of the NetZero Program in 2023 . This milestone is a key step in the transformation of the platform proven YpsoMate autoinjector into a zero-carbon emission …

Clicking sounds of autoinjectors: A method to assess the audibility considering the spectrum of human hearing

To make sure people with visual and hearing impairments can use the YpsoMate autoinjectors without limitations, the devices are tested at METAS regarding the effectiveness of their acoustic signals.
Load more